MA42889B2 - Triple activator activating the glucagon, glp-1 and gip receptor - Google Patents
Triple activator activating the glucagon, glp-1 and gip receptorInfo
- Publication number
- MA42889B2 MA42889B2 MA42889A MA42889A MA42889B2 MA 42889 B2 MA42889 B2 MA 42889B2 MA 42889 A MA42889 A MA 42889A MA 42889 A MA42889 A MA 42889A MA 42889 B2 MA42889 B2 MA 42889B2
- Authority
- MA
- Morocco
- Prior art keywords
- glp
- glucagon
- gip receptor
- triple activator
- activator activating
- Prior art date
Links
- 239000012190 activator Substances 0.000 title abstract 3
- 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 title abstract 2
- 101100125311 Escherichia coli (strain K12) hyi gene Proteins 0.000 title abstract 2
- 101150039312 GIP gene Proteins 0.000 title abstract 2
- 102000051325 Glucagon Human genes 0.000 title abstract 2
- 108060003199 Glucagon Proteins 0.000 title abstract 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title abstract 2
- 229960004666 glucagon Drugs 0.000 title abstract 2
- 230000003213 activating effect Effects 0.000 title 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne un triple activateur qui active le récepteur du glucagon, du glp-1 et du gip, et des applications de ce triple activateur.The present invention relates to a triple activator which activates the receptor for glucagon, glp-1 and gip, and applications of this triple activator.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150191082 | 2015-12-31 | ||
| PCT/KR2016/015554 WO2017116204A1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA42889A1 MA42889A1 (en) | 2018-11-30 |
| MA42889B2 true MA42889B2 (en) | 2020-11-30 |
Family
ID=62104015
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42891A MA42891B2 (en) | 2015-12-31 | 2016-12-30 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
| MA42889A MA42889B2 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating the glucagon, glp-1 and gip receptor |
| MA51955A MA51955B1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
| MA53533A MA53533A1 (en) | 2015-12-31 | 2018-07-26 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42891A MA42891B2 (en) | 2015-12-31 | 2016-12-30 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51955A MA51955B1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
| MA53533A MA53533A1 (en) | 2015-12-31 | 2018-07-26 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
Country Status (3)
| Country | Link |
|---|---|
| AR (2) | AR107282A1 (en) |
| MA (4) | MA42891B2 (en) |
| MY (1) | MY199261A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3842449A1 (en) * | 2019-12-23 | 2021-06-30 | Merck Sharp & Dohme Corp. | Stapled olefin co-agonists of the glucagon and glp-1 receptors |
-
2016
- 2016-12-30 MA MA42891A patent/MA42891B2/en unknown
- 2016-12-30 MA MA42889A patent/MA42889B2/en unknown
- 2016-12-30 MY MYPI2018001199A patent/MY199261A/en unknown
- 2016-12-30 MA MA51955A patent/MA51955B1/en unknown
-
2017
- 2017-01-02 AR ARP170100004A patent/AR107282A1/en unknown
- 2017-01-02 AR ARP170100003A patent/AR107281A1/en unknown
-
2018
- 2018-07-26 MA MA53533A patent/MA53533A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA42889A1 (en) | 2018-11-30 |
| AR107281A1 (en) | 2018-04-18 |
| MA53533A1 (en) | 2022-08-31 |
| MA51955B1 (en) | 2022-04-29 |
| MA42891A1 (en) | 2019-04-30 |
| MA42891B2 (en) | 2021-11-30 |
| MA51955A1 (en) | 2021-10-29 |
| AR107282A1 (en) | 2018-04-18 |
| MY199261A (en) | 2023-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018008027A (en) | Triple activator activating glucagon, glp-1 and gip receptor. | |
| MX2020003217A (en) | Long-acting co-agonists of the glucagon and glp-1 receptors. | |
| MA49545B1 (en) | Glucagon derivative and composition comprising a long-acting conjugate thereof | |
| MX377710B (en) | MONOCLONAL ANTIBODIES AGAINST BCMA. | |
| PE20180395A1 (en) | SOLID DOSAGE FORMS OF PALBOCICLIB | |
| EA201792612A1 (en) | 6-AMINOHINOLIN-3-CARBONITRILES AS COT MODULATORS | |
| CL2019003599S1 (en) | Extinguisher. | |
| WO2017074798A3 (en) | Long-acting co-agonists of the glucagon and glp-1 receptors | |
| EA201890828A1 (en) | OPTIMIZED TABLET WITH HIGH DOSE OF ACTIVE COMPOUND, CONTAINING MESALAZIN | |
| EP3867483A4 (en) | SELF-RETRACTING STEP | |
| EA201792527A1 (en) | TREATMENT OF ZUD | |
| MX394179B (en) | LIRAGLUTIDE IN CARDIOVASCULAR DISEASES. | |
| MA42889B2 (en) | Triple activator activating the glucagon, glp-1 and gip receptor | |
| ECSP17085737A (en) | SOLID DOSAGE FORMS OF PALBOCICLIB | |
| CL2015000874A1 (en) | Pde9i with main structure of imidazopirazinone | |
| UA104671U (en) | Application of iakton as neuroprotective agents. | |
| UA101750U (en) | Use of omega as organoprotector in toxic hepatitis | |
| TN2014000522A1 (en) | لوح مدرسي بوجهين | |
| UA100710U (en) | APPLICATION OF FITOVENOL Capsules AS A HEPATOPROTECTOR |